NextCure

NXTCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$23.619 M

$5.16 -11.79%

Close of 6 Nov 2026

As of 6 Nov 2026, NextCure (NXTC) has a market capitalization of $23.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$55.8M

Loss-making

Shares outstanding

4,577,359

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#373Shuttle PharmaceuticalsSHPH$24.3M
#374CelularityCELU$23.7M
#375NextCureNXTC$23.6M
#376China PharmaCPHI$23.5M
#377Mira PharmaceuticalsMIRA$23.0M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of NextCure, worth $1.71M. Grants and option exercises are excluded.

ADAR1 Capital Management, LLC, Daniel Schneeberger$1.62M
329,153 shares at $4.93 on 30 Jul 2026 · filed 3 Aug 2026
ADAR1 Capital Management, LLC, Daniel Schneeberger$87.7K
17,608 shares at $4.98 on 27 Jul 2026 · filed 29 Jul 2026

What if NextCure were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,168,814

Per share 1,195,507× higher

Bitcoin $1.53T

$333,783.76

Per share 64,687× higher

Apple $5.02T

$1,095,781

Per share 212,361× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for NextCure are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.